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Background: Controlling the false discovery rate is important when testing multiple hypotheses. To enhance the
detection capability of a false discovery rate control test, we applied the likelihood ratio-based multiple testing
method in neuroimage data and compared the performance with the existing methods.
Methods: We analysed the performance of the likelihood ratio-based false discovery rate method using simulation
data generated under independent assumption, and positron emission tomography data of Alzheimer’s disease and
questionable dementia. We investigated how well the method detects extensive hypometabolic regions and
compared the results to those of the conventional Benjamini Hochberg-false discovery rate method.
Results: Our findings show that the likelihood ratio-based false discovery rate method can control the false discovery
rate, giving the smallest false non-discovery rate (for a one-sided test) or the smallest expected number of false
assignments (for a two-sided test). Even though we assumed independence among voxels, the likelihood ratio-based
false discovery rate method detected more extensive hypometabolic regions in 22 patients with Alzheimer’s disease, as
compared to the 44 normal controls, than did the Benjamini Hochberg-false discovery rate method. The contingency
and distribution patterns were consistent with those of previous studies. In 24 questionable dementia patients, the
proposed likelihood ratio-based false discovery rate method was able to detect hypometabolism in the medial
temporal region.
Conclusions: This study showed that the proposed likelihood ratio-based false discovery rate method efficiently
identifies extensive hypometabolic regions owing to its increased detection capability and ability to control the
false discovery rate.Background
Several multiple hypothesis testing methods have been
proposed for use in neuroimaging studies. Bonferroni
correction is the simplest but the most conservative
method for controlling the family-wise error rate (FWER).
However, it often fails to detect voxels with real activation
or difference. As an alternative approach, the Benjamini
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unless otherwise stated.discovery rate (FDR) was applied to neuroimaging stud-
ies by Genovese, Lazar and Nichols [2]. The FDR con-
trol gives statistically less conservative procedures than
FWER. However, Cohen and Sackrowitz [3] proved that
the Benjamini and Hochberg procedure is inadmissible
under any loss function that is a linear combination of
false discoveries and false non-discoveries. Given a fixed
FDR, it is desirable to maximize the power by minimiz-
ing the false non-discovery rate (FNDR).
Recently, Lee and Bjørnstad [4] proposed a new multiple
hypothesis test based on the likelihood-ratio-based FDR
(LR-FDR). They showed that the problem of large-scale
multiple testing is naturally expressed as an inference
problem for finding the true discoveries. And they repre-
sented the underlying effects of interest by the (unknown)is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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types of unknowns, namely parameters (fixed unknowns)
and unobservables (random unknowns). Bjørnstad [5]
showed that all information on parameter and unob-
servable data was in the extended likelihood, such as the
h-likelihood [6]. Lee, Nelder and Pawitan [7] extensively
introduced a random effect analysis using the extended
likelihood. More recently, Lee and Bjørnstad [4] showed
how the extended likelihood can be used to derive their
proposed LR-FDR method. This method is optimal
when (a) determining the order in which the test results
can be called significant and (b) controlling error rates
given this order. Provided an assumed statistical model
is true, the likelihood exploits all information in the data
to provide the most efficient testing. Therefore, it is
important to search for the best-fitting model enhancing
the performance of a multiple hypothesis test. The likeli-
hood approach provides various well-developed model-
checking and model-selection procedures.
In reviewing existing multiple tests, Efron [8] began by
summarizing statistics such as p-values [1] and test statis-
tics [8]. He then described how to find a single-threshold
rule for such statistics by assuming a common alternative.
A typical analysis process is involved in model selection
and model prediction. Model selection aims to find a par-
simonious, well-fitting model for the basic responses and
model prediction uses summarizing statistics from the pri-
mary analysis to make statistical inferences [9]. However,
starting with the summarizing statistics makes the model
selection for the basic responses secondary and difficult,
leading to inefficient tests [4]. In addition, assumptions
about a common alternative may not always be feasible.
For BH-FDR, the conventional t-statistics (and corre-
sponding p-value) are used for testing the difference of
means between two groups. The LR-FDR method models
with the basic response, not summarizing statistics, which
allows for different alternatives for each test. The likeli-
hood approach provides an efficient way of controlling the
FDR by simultaneously minimizing the FNDR and the
useful information such as consistent estimates of effect
size or proportion of null hypotheses.
In this study, we first applied the LR-FDR method to
simulated data with extensive alternative proportion
(hypometabolic areas in neuroimaging data) and then to
brain positron emission tomography (PET) data of three
groups: Alzheimer’s disease (AD), questionable dementia
(QD), and normal controls (NC). QD is also known as
mild cognitive impairment (MCI), and the QD patients
in our study were particularly at risk of developing
dementia in the near future. We extended the model of
Lee and Bjørnstad [4] to allow the distribution of test-
statistic is asymmetric.
We compared the LR-FDR method to conventional
thresholding using Benjamini and Hochberg’s FDR(BH-FDR), to establish its efficiency when determining
hypometabolic regions in AD and QD groups.
Methods
The LR-FDR method
Consider a hierarchical model for the basic responses.
For the νth location within the brain and the jth individ-
ual in the control group (ν = 1, …, N and j = 1,…, n1),
suppose that the response yvj1 is modeled by
yvj1 ¼ ξv þ evj1; ð1Þ
where ξv is the mean parameter and evj1 ~N(0, ϕv1).
Then, the treatment (or disease) group has n2 individuals
(j = 1,…, n2), and the response yvj2 is modeled by
yvj2 ¼ ξv þ wv þ evj2; ð2Þ
where wv is the treatment (or disease) effect, and
evj2 ~N(0, ϕv2). Thus, conditional on wv, the difference
between the means of the two groups,
dv ¼ yv2 − yv1; ð3Þ
follows N(wv,ψv), with ψv = ϕv1/n1 + ϕv2/n2 and y
v1 ¼ Pj
yvjk=nk , for v = 1,…,N and k = 1, 2. To estimate ψ =
(ψ1, …,ψN), we use the unbiased estimators of ϕvk (v =











¼ ϕ^ v1=n1 þ ϕ^ v2=n2: ð4Þ
To complete the model, specify the model for the
treatment effects, wv.
One-sided test
Let the null hypothesis Hv be the vth voxel is not abnor-
mally activated (not different between two groups).
Following Lee and Bjørnstad [4], we defined the binary
random variable ov, such that ov = 0 if the null hypothesis
Hv is true, ov = 1 if Hv is false, and ps = P(ov = s) for s = 0
or 1, with p0 + p1 = 1. Now, the multiple test problem
can be viewed as predicting ov.
Conditional on ov, assume that wv follows the normal
distribution:
Given ov ¼ 0;wv e N 0; σ2 ;
given ov ¼ 1;wv e N μ; τ2 :
Here, we consider only normal distribution for wv.
However, this likelihood approach can be easily extended
to other distributions. In this study, we prefer to have
σ2 > 0 since, typically, the null hypotheses “wv = 0” are
never exactly true, but rather wv = 0, which can be
Table 1 The outcomes of N multiple hypothesis tests
Non-discovery Discovery Total
Null N0 − V V N0
Alternative N − N0 − S S N − N0
Total N − D D N
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2. Here, ψv in (4) represents
the within-test variation, σ2 the between-test variation
for Uninteresting cases, and τ2 the between-test vari-
ation for the Interesting cases. If ψv is assumed to be
common (i.e., ψv = ψ for all v), this means that there is
nothing special about any voxel in the alternative, and
they are all statistically exchangeable. How can we de-
termine whether voxels are all (statistically) exchange-
able? Since we assume that the ψvs are not common
and estimate them separately, we have a statistical
model that allows all active voxels to have the same
mean effect, but with different sampling variances. In
addition to ϕv1 and ϕv2, in this model, we have the
fixed parameters θ = (p0, μ, σ
2, τ2).
We denote d = (d1, …, dN)
T and let w and o be the
vectors of wv and ov, respectively. In this study, o is the
inferential focus and w is a nuisance parameter which
can be integrated out as follows:
log f θ d; oð Þ ¼ log
Z




log f θ dv ovÞ þ log f θ ovð Þ;jð½
where
log f θðdvjovÞ ¼ I ov ¼ 0ð Þ −
1
2




2 ψv þ σ2ð Þ
 





2 ψv þ τ2ð Þ
" #
log f θ ovð Þ ¼ I ov ¼ 0ð Þ logp0 þ I ov ¼ 1ð Þ log 1−p0ð Þ;
where I(∙) is the indicator function.
To estimate the fixed parameters, θ, Lee and Bjørnstad
[4] used the maximum-likelihood (ML) estimator for the
log-likelihood,
l θð Þ ¼
XN
v¼1
log f θ dvð Þ; ð5Þ
where log fθ(dv) = ∑ov log fθ(dv, ov) and ψv are substituted
by ψ^v: This avoids the downward bias of the ML estimation
owing to the large number of nuisance parameters, ψv, in
the model [4].
Since fθ(dv, ov) is a density function for a mixture, the
unboundedness of likelihood might occur without a
proper constraint on the parameters. However, Hath-
away [10] pointed out that this problem can be resolved
by a local maximizer of the likelihood in the interior of
the parameter space that is consistent and asymptotically
efficient. Therefore, to avoid the unboundedness prob-
lem, we are actually looking for a good local maximum
of the likelihood, which would satisfy both σ^ 2 > 0 andτ^2 > 0 [11]. To estimate θ, we used the expectation-
maximization (EM) algorithm of Dempster, Laird and
Rdin [12], with the proper initial values.
Let δv be a test for the vth null hypothesis, Hv : δv = 0
(non-discovery) if Hv is not rejected, and δv = 1 (discovery)
if Hv is rejected. For some α > 0, consider the loss function




I ov ¼ 1ð ÞI δv ¼ 0ð Þ
þαI ov ¼ 0ð ÞI δv ¼ 1ð Þ:
ð6Þ
Lee and Bjørnstad [4] showed that the optimal deci-




, that minimizes the risk with the
loss function (6) is
δαv ¼ 1 if R dv; θð Þ > α;
¼ 0 otherwise;
where R dv; θð Þ ¼ Pðov¼1jdvÞPðov¼0jdvÞ ¼
p1N dv;μ; ψvþτ2ð Þ
p0N dv;0; ψvþσ2ð Þ is the likeli-
hood ratio. Among tests with the common expected
number of discoveries, this test is optimal in the sense
that it controls the FDR with the smallest FNDR.
The outcomes of multiple tests can be summarized as
in Table 1. Following Lee and Bjørnstad [4], we define
the FDR and FNDR as E(V)/E(D) and E(N −N0 − S)/E
(N −D), respectively. Benjamini and Hochberg defined
the Fdr as E(V/D), but Genovese and Wasserman [13]
showed that Fdr = E(V/D) and FDR = E(V)/E(D) are
asymptotically equivalent (in N) if the tests are independ-
ent. Suppose we want a test with an FDR level of κ. In this
study, we first estimate the FDR as FDR αð Þ^, for each α.
Then, we search for the cutoff α such that FDRðαÞ ¼ κ^




; with an FDR con-
trol of κ. Lee and Bjørnstad [4] used the following estimator:
FDR αð Þ^¼ E Vð Þjθ¼θ^
D
;
which works well in their examples from genetic studies
in which N is of the order of several thousands. However,
in brain images for which N = 329,694 > > 10,000, we
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avoid this problem, we use the estimator
FDR αð Þ^¼ E Vð Þjθ¼θ^








In our models, δαv ¼ I R dv; θð Þ > αð Þ ¼ I dv < clv or dv > cuv
 
.
For a given α, the cutoff values clv and c
u
v can be solved
numerically from the equation R(dv; θ) = α. Then,
E Vð Þ ¼
X
P ov ¼ 0; δαv ¼ 1












E Sð Þ ¼
X
P ov ¼ 1; δαv ¼ 1
















where Φ(∙) is the cumulative distribution function of a
standard normal distribution and ~Φ ∙ð Þ ¼ 1−Φ ∙ð Þ: By
plugging in the estimates of θ, we obtain an estimator
for the FDR.
Two-sided test
In a two-sided problem, we may take only two actions.
We can either simply accept or reject the null hypothesis
without distinguishing between the positive and negative
effects. In the case of brain data, it is important to assign
abnormal regional changes at the voxel level. An abnor-
mal voxel can be defined as an abnormally positive
(hypermetabolic) or negative (hypometabolic) state. Es-
pecially positive activity might be associated with a treat-
ment effect after treatment or functional compensation,
while negative activity might be associated with func-
tional deficit. This statistically specific determination of
an abnormal voxel influences clinical interpretations.
Therefore, this method allows us to consider the sign of
the test statistic to decide whether the alternative discov-
ery is positive or negative when the null hypothesis is
rejected. In other words, we would never conclude that
there is a discovery without stating whether the effect is
positive or negative. As we show in the discussion on
our results, in neuroimaging, an entire alternative can be
either hypermetabolic or hypometabolic, whereas in
genetics, alternatives often exist in both directions.
Extending the one-sided test model from the previous
section, we used the two-sided multiple testing with three
actions of Lee and Bjørnstad [4]. Here, the discrete ran-
dom variable, ov, takes one of the three states: (a) ov = 0
if the ith case is “Uninteresting;” (b) ov = 1 if the ith case
is “Interesting, with a Positive effect;” and (c) ov = − 1 ifthe ith case is “Interesting, with a Negative effect.” In
addition, ps= P(ov= s) for s =− 1, 0, 1, with p0 + p1 + p− 1 = 1.
Consider the differences in (3). Suppose that, condi-
tional on ov, wv follows a normal distribution, as follows:
Given ov ¼ 0;wv eN 0; σ2 ;
given ov ¼ 1;wv eN μP; τ2P ;
given ov ¼ −1; wv eN −μN ; τ2N ;
where μP, μN > 0. For simplicity of arguments, in this
paper, we assume that μP = μN = μ and τ2P ¼ τ2N ¼ τ2 . In
this model, we have the fixed parameters θ= (p0, p1, μ, σ
2, τ2),
yielding a three-mixture model. Thus, we can use the EM
algorithm to estimate θ. Since ov takes one of three states,
the decision rule δv also takes a value in {0, 1, − 1}. In other
words, δv = 0 (non-discovery) if Hv is not rejected, δv = 1
if Hv is rejected with a positive effect, and δv = − 1 if Hv
is rejected with a negative effect.
For some α+ > 0 and α− > 0, consider the loss function




I ov≠0ð ÞI δv≠ovð Þ
þI ov ¼ 0ð ÞfαþI δv ¼ 1ð Þ
þ α−I δv ¼ −1ð Þg
i
ð7Þ
Then, the optimal decision rule that minimizes the risk
in the loss function (7) is
δαþ ;α−v ¼ 1 if Rþ dv; θð Þ > αþ and Rþ dv; θð Þ−R− dv; θð Þ > αþ−α−;
¼ −1 if R− dv; θð Þ > α− and Rþ dv; θð Þ−R− dv; θð Þ < αþ−α−;
¼ 0 otherwise:
where
Rþ dv; θð Þ ¼ Pðov ¼ 1jdÞP ov ¼ 0jdð Þ ¼
p1N dv; μ; ψv þ τ2ð Þ
p0N dv; 0; ψv þ σ2ð Þ
;
R− dv; θð Þ ¼ Pðov ¼ −1jdÞP ov ¼ 0jdð Þ ¼
p−1N dv;−μ; ψv þ τ2ð Þ
p0N dv; 0; ψv þ σ2ð Þ
:
If we control the FDR at level κ for both directions
using α+ and α−, the resulting two-sided test with three
actions maintains the FDR at the same level. Further-
more, this optimal test allows more flexible analysis
which can control the FDR at different level for each dir-
ection, for example, 0.05 for positive direction and 0.01
for negative direction. In fact, Lee and Bjørnstad [4]
showed that the resulting multiple two-sided test with





number of false assignments.
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Simulation data were generated with a dimension of
400 × 400 pixels. We set the proportion of positive pixels
to 80% (Simulation I) and 60% (Simulation II) per
160,000 total pixels, considering that the estimates of p1
were high in our PET data. For each simulation setting,
we varied μ = 1, 3, 5 and fixed σ2 = 0.3 and τ2 = 0.5.
From (1) and (2), we randomly generated yvj1 and yvj2
for v = 1,…, 160, 000, j1 = 1,…, 30, and j2 = 1,…, 30. For
each simulation, we generated 100 simulation data sets
and applied both the LR-FDR and BH-FDR methods to
control the FDR at the 0.05 level.
AD and QD PET data
PET data were composed of two types of patient groups
and one control group. The first group consisted of 22
probable AD patients (mean age, 66.9 ± 7.2) with moder-
ate dementia according to the criteria of the Mini-
Mental State Examination (MMSE), with a mean MMSE
score of 13 ± 5.0, and a Clinical Dementia Rating (CDR)
score between 1 and 3. Generally, the MMSE score can
be indicated severe (<9), moderate (10–18), mild (19–24)
cognitive impairment. The AD patients suffered progres-
sive memory loss, but had no disturbance of conscious-
ness. The second group comprised 24 QD patients (mean
age, 67.3 ± 9.0) who showed objective evidence of memory
and/or cognitive impairments, but did not satisfy the
criteria for AD. Their CDR scores were all 0.5, and their
mean MMSE scores were 23 ± 4.1.
All the patients were diagnosed by clinical evaluation
using the National Institute of Neurological and Com-
municative Disorders and Stroke and Alzheimer’s Dis-
ease and Related Disorders Association AD criteria as a
guideline. The two patient groups described above were
compared with 44 normal control (NC) subjects (mean
age, 68.9 ± 5.2). These NC subjects were recruited from
the Health Care Center at Seoul National University
Hospital and had no history of neurological disorders,
psychiatric disorders, significant medical conditions, or
substance abuse. For subject screening, the Korean ver-
sion of the modified MMSE and the Mood Evaluation
Scale were used, and only right-handed subjects were
included in the study. Furthermore, there was no signifi-
cant age difference among the three groups. This study
was approved by the institutional review board (IRB) of
the Seoul National University Hospital. PET data of our
patients were only part of the patient’s standard care.
We used patient’s data from database obtained from
1996 to 1999. Normal controls were recruited for other
study purpose (i.e., creation of Korean Standard Brain
Template) from Center for Health Promotion and Opti-
mal Aging of Seoul National University Hospital in 2001
[14], who provided informed consent which was verbal
form. For our research using identifiable human data,such as PET data in database of department, although
we didn’t receive documented informed consent from
participants, IRB of our institute decided that this study
protocol was applicable to exceptional situations where
consent would be impracticable to obtain due to reuse
storage data in database. Also our study was conducted
in a manner that minimizes possible abuse to human
subject’s health and rights and no clinical intervention
was performed for our study.
PET image acquisition
18 F-FDG PET images were obtained using an ECAT
EXACT 47 (Siemens-CTI, Knoxville, TN, USA) PET
scanner with an intrinsic resolution of 5.2 mm FWHM.
After obtaining a transmission scan measured by 68Ge rod
sources for attenuation correction, an emission scan was
obtained. During the resting state, 18 F-FDG was adminis-
tered in doses of 370 MBq (10 mCi) for 30 min to obtain
a static emission scan. All participants were scanned
under the normal environmental noise conditions in the
scanner room. For transaxial image reconstruction a fil-
tered back-projection algorithm (Shepp-Logan filter at a
cutoff frequency of 0.3 cycles/pixel as 128 × 128 × 47
matrices of size 2.1 × 2.1 × 3.4 mm) was used.
Image processing
All PET images were preprocessed using Statistical
Parametric Mapping (SPM 2, University College of London,
UK) and implemented in the Matlab 6.5 (Mathworks
Inc., USA) environment. After spatial normalization to
the Montreal Neurological Institute (MNI) space, all im-
ages were smoothed with a Gaussian filter of 16 mm full
width at half maximum (FWHM). The PET signal inten-
sity was normalized to the individual’s total mean count
for the cerebellum. This region was chosen as a refer-
ence region because it remains relatively unaffected
until late in the progression of AD, if at all. To remove
non-brain voxels, normalized and smoothed PET im-
ages were exclusively masked with a binary brain mask
image. The same masked PET images were applied to
both LR-FDR and BH-FDR methods using R software.
Results
Simulation results
We applied the proposed LR-FDR method to the simu-
lated data set. The simulated data had a pixel dimension
of 400 × 400, which yielded a total 160,000 tests. We
considered two simulation settings with varying p1, the
proportion of pixels with ov = 1: p1 was 80% in Simula-
tion I and 60% in Simulation II. Figure 1 shows the FDR
and FNDR results based on the 100 simulated data sets.
The LR-FDR method yielded a smaller FNDR than the
BH-FDR method (Figure 1): 20% lower when μ = 3 or 5
in Simulation I (p1 = 80%) and 5% lower when μ = 3 in
Figure 1 The averaged FDR and FNDR. Within each panel, black and white bars represent the BH-FDR and LR-FDR methods, respectively. The
alternative proportions of data are 80% and 60% in Simulation I (A and B) and II (C and D), respectively. In each simulation setting, depending
on μ, three parameter settings are presented.
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FDR results quite close to 0.05 in both simulation
settings. The minimum and maximum of the average
FDR from the 100 repeated tests were 0.049 and 0.056,
respectively, across all settings. The BH method often
yielded a more conservative FDR control for most of the
settings.Results of the AD and QD data analysis
In probable AD cases, all methods (one-sided test of
LR-FDR, two-sided test of LR-FDR, conventional BH-FDR
methods) revealed hypometabolic regions at FDR level
0.01 (Figure 2). Both the one-sided and two-sided tests of
LR-FDR showed hypometabolism in the bilateral posterior
cingulate, frontal, temporal, and parietal areas, the extent
of which was wider than that shown by conventional BH-
FDR. More specifically, the LR-FDR method showed that
the hypometabolic regions spread to the posterior pre-
frontal and anterior occipital regions in the AD group. No
hypometabolic areas were observed in the sensorimotor
and visual areas by any of the methods. Quantification
using the LR-FDR method generally found a greater num-
ber of voxels than did the BH-FDR method (Table 2). In
the QD cases, the LR-FDR method showed hypometabolic
regions in both medial temporal areas, including the
hippocampus and anterior frontal cortex (Figure 3). Thehypometabolic voxels in the medial temporal regions were
found more easily using LR-FDR method at 0.05, 0.01,
0.005, and 0.001. However, no hypometabolic region was
found by BH-FDR method with controlling FDR at 0.01
(Table 3).
The estimates of the fixed parameters are shown in
Table 4. In the AD cases, two-sided tests give the effect
size, μ^ = 4.524, and the estimated probability of “Inter-
esting, with a Negative effect,” p^−1 = 0.771. Since p^1
approaches 0 in the two-sided test, both tests have the
same parameter estimates and the same number of
significant voxels. In the QD cases, very few hypermeta-
bolic region was found.




at the null ov = 0
was N (0, 1). However, Figure 4 shows that most tv -values
for both the AD and QD groups were located on the left
of the theoretical null distribution, N (0, 1). Lee and
Bjørnstad [4], when analyzing genetic data, assumed that
p1 = p− 1, but we did not do so here, as in our neuroimag-
ing data, p1≪ p− 1. For both the AD and QD PET data,
the symmetric model (with p1 = p− 1) was not plausible.
Therefore, we avoided using the wrong symmetric model
by estimating, p1 and p− 1 separately. To check the good-
ness of fit, we first generated a synthetic sample, dv ; from
the fitted model, fθ(dv), using the estimated parameters in
Table 4. Figure 4 shows the histogram of dv . Since the
shapes of the histograms of the dv (from the real data) and
Figure 2 Brain regions with significantly lower FDG uptake in probable AD compared to NC. Regions with lower FDG uptake in probable
AD are displayed. The left hemisphere is shown as a 3D volume rendering. The reduction in the FDG uptake in the temporal, parietal, and
posterior prefrontal regions was commonly found in the LR-FDR and BH-FDR methods. Extensive hypometabolic areas extending to posterior
prefrontal were detected with the LR-FDR one-sided and two-sided tests. The color bar range from minimum to maximum significance level
denotes the significance of the likelihood ratio in both LR-FDR methods and of the p-value in BH-FDR method. (AD: Alzheimer’s disease; FDR:
False discovery rate; LR-FDR: Likelihood ratio false discovery rate; NC: Normal controls).
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that resulting model fitting was appropriate.
In AD group, the result of the LR-FDR one-sided test
was the same as that of the LR-FDR two-sided test with
three actions, because in these data, there was no positiveTable 2 Total number of voxels in the whole brain with
significant hypometabolism at different threshold levels
Comparisons Threshold
levels






NC > AD FDR 0.001 194789 194789 165451
FDR 0.005 213881 213881 207426
FDR 0.01 223091 223091 221507
FDR 0.05 249706 249706 251100
NC > QD FDR 0.001 8471 7740 47
FDR 0.005 18094 16767 140
FDR 0.01 25624 23813 212
FDR 0.05 53229 50287 22038
AD: Alzheimer’s disease; NC: Normal controls; QD: Questionable dementia.effect (p^1 ¼ 0). In other words, no hypermetabolic region
was found in AD patient group.Discussion
In this study, we applied the LR-FDR method to neuro-
imaging data. We found that the LR-FDR method in-
creased the detection capability in the simulated as well as
brain PET data, allowing us to decrease the FNDR and
find larger areas of abnormality under the given level of
the FDR, respectively. Decreasing the FNDR worked when
the difference of the means of the two groups was within
a range specified in the simulation study. When we com-
pared the two patient groups (AD and QD) with NC
group, the three actions of 1, 0, and −1, corresponding to
positive (normal < patients), null (normal = patients), and
negative (normal > patients) differences, revealed areas of
hyper-, eu-, and hypo-metabolism, respectively. Only
negative results (i.e., hypometabolism) in AD patients as
compared to normal were obtained and visualized in
both the one-sided test and the two-sided test with
three actions. In the two-sided test with three actions,
Figure 3 Brain regions with significantly lower FDG uptake in QD compared to NC. The coronal view in the left column shows
hypometabolism in the medial temporal regions in QD. An anatomical map of the hippocampus is displayed in blue. Regions with a
lower FDG uptake are displayed in red. The LR-FDR one-sided and two-sided tests disclosed more extensive hypometabolic areas in
both temporal lobes than did the BH-FDR method. (FDR: False discovery rate; LR-FDR: Likelihood ratio false discovery rate; NC: Normal
controls; QD: Questionable dementia).
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http://www.biomedcentral.com/1471-2288/15/9the estimated probability of a hypermetabolic region
was zero in cases with AD. In these cases, extensive
regional metabolic reduction was found throughout the
brain, with the same degree, by the one-sided test and
two-sided test with three actions.
In existing literature, several reports have stated that
abnormalities in glucose metabolism are probably present
in the medial part of the temporal lobes early in the devel-
opment of AD [15,16]. QD or MCI subjects (CDR score
of 0.5) are likely to show initial minor abnormalitiesTable 3 Total number of voxels in hippocampus with
significant hypometabolism at different threshold levels
Comparisons Threshold
levels








NC > QD FDR 0.001 0/117 0/117 0/0
FDR 0.005 1/181 1/184 0/0
FDR 0.01 12/217 12/217 0/0
FDR 0.05 118/303 121/303 0/158
NC: Normal controls; QD: Questionable dementia.[17,18] that, in some cases, have progressed to probable
AD upon follow-up [16,19,20]. Various investigators have
attempted to find the predictive areas of abnormality, by
using both FDG PET [16] and MRI using voxel-based
morphometry [21], to predict future development of AD.
Among these predictors are medial temporal lobe involve-
ment of MRI signal loss (atrophy) [18-21], accumulation
of neutritic plaques [22], and hypometabolism [16,23].
The expansion of hypometabolism to the temporal,
cingulate, or other cortices was a common finding in
AD. However, the right/left asymmetry of involvement
or the exact nature of the abnormality in the hippocampus
shown by FDG PET or MRI has not been consistentlyTable 4 Parameter estimates
Comparisons Tests μ σ2 τ2 P0 P1 P−1
NC > AD One-sided −4.524 0.001 9.437 0.229 0.771 -
Two-sided 4.524 0.001 9.437 0.229 0.000 0.771
NC > QD One-sided −1.437 0.000 0.696 0.669 0.331 -
Two-sided 1.479 0.000 0.594 0.674 0.004 0.323
AD: Alzheimer’s disease; NC: Normal controls; QD: Questionable dementia.
Figure 4 Histograms of real and synthetic data. Histograms of dv of the generated synthetic data from fitted model (gray histogram) and dv
of real data (hatched histogram) (left: AD cases, right: QD cases) (AD: Alzheimer’s disease; QD: Questionable dementia).
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http://www.biomedcentral.com/1471-2288/15/9reported [18,24-26]. This might be due to differences
between patients and the normal populations examined,
but might also be due to differences in the statistical
methods used to detect abnormalities. Thus far, consid-
erable effort has been made to control false positives,
but less effort has gone into minimizing false negatives.
Using this novel LR-FDR method to minimize the
FNDR, we found right-dominant abnormalities in the
hippocampus in a relatively small patient group.
Using simulation studies, we showed that the LR-FDR
method controlled the FDR quite near to the stated
level. In contrast, the BH-FDR method did not maintain
the stated FDR level, and instead became more conserva-
tive (i.e., a lower FDR then set beforehand). Furthermore,
the LR-FDR method reduced the FNDR significantly in
certain situations, according to the simulation study, as
compared to the BH-FDR method. The FNDR reduction
became greater as p1 increased. In the neuroimaging data,
such as the AD PET data, p1 was larger (e.g., 0.771),
whereas in the genomic studies, p1 was often small (i.e.,
less than 0.05). The BH-FDR method assumes that σ2 = 0.
However, the LR-FDR method allows for non-zero
between-test variations (σ2 > 0 or τ2 > 0). In our PET study
using real imaging data, we found that the maximum like-
lihood estimates of τ2 are very different from zero. In a
neuroimaging data analysis, the LR-FDR method was pre-
ferred over the BH-FDR method. The LR-FDR method
had a higher detection capability, and showed extensive
hypometabolic regions in patients with AD or QD. Espe-
cially, in QD group, no significant area was found in BH-
FDR at 0.01, although the hypometabolic voxels were 229in LR-FDR method. One possibility is that the hippocam-
pal region was falsely assigned as a null in the BH-FDR
method at this threshold level.
The data used in this study were drawn from Lee,
Kang, Jang, Cho, Kang, Lee, Kang, Lee, Woo and Lee
[27], and the assessment of cerebral glucose metabolism
by FDG-PET in a resting state correlated well with the
progression of disease severity in patients with AD
[23,28]. Unlike patients with cognitive deterioration as-
sociated with old age, patients with AD showed de-
creased FDG uptake in both parietal regions, including
the posterior cingulate and temporal areas and the
frontal cortices, as the disease progressed [29,30]. Pri-
mary sensory and motor cortices, as well as visual and
deep gray cortices remained relatively intact in AD until
late in the disease progression [31]. FDG-PET results,
analyzed by all three methods, showed a characteristic
spatial pattern of glucose hypometabolism in the par-
ietal, temporal, and posterior prefrontal regions in pa-
tients with AD, as compared to the NC group. In AD
cases, the pattern of distribution was similar. However,
unlike the conventional methods, the LR-FDR method
showed more extensive hypometabolic areas, extending
symmetrically to posterior prefrontal cortices.
Hippocampal atrophy was once thought to be a dis-
criminant feature in individuals with MCI at risk of AD
[18,21]. In our investigation, the LR-FDR method could
disclose that reduced FDG uptake in the hippocampal
region is a discriminator between normal and QD pa-
tients [32,33]. The BH-FDR method showed no temporal
hypometabolic result. In contrast, the LR-FDR method
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http://www.biomedcentral.com/1471-2288/15/9revealed hypometabolism in bilateral medial temporal
areas. The hypometabolism seen on the right side was
more extensive and severe in LR-FDR method.
We showed that the LR-FDR method for two-sided
multiple testing with three actions can be applied to
neuroimaging data analysis to find hypermetabolic or
hypometabolic regions. In the search for a pre-symptomatic
imaging biomarker in the prodromal phase of AD (i.e., QD),
we propose that the LR-FDR method is the most efficient
tool and, therefore, optimizes the chances for success. Ac-
cording to the good fitting of the model shown in Figure 4,
we could say that the non-symmetric model fitting and
efficient analysis was feasible to yield robust results from
the LR-FDR method, using either the one-sided test or
two-sided test with three actions. In the non-symmetric
cases, none of the methods employed by Lee and Bjørnstad
[4] worked, assuming p1 = p− 1. This is the advantage our
LR-FDR method holds, when applied to neuroimaging
data, over any existing p-value based methods.
The extended likelihood principle of Bjørnstad [5]
means that if the assumed model is correct, all informa-
tion on the unknowns is in the extended likelihood.
Therefore, this can be the basis for the most efficient
test. However, if the assumed model is not correct, the
likelihood method may fail. All the existing multiple test-
ing procedures have been developed without considering
a proper model choice, so that, as Lee and Bjørnstad [4]
showed, existing methods may not maintain the stated
FDR level if any of their model assumptions are wrong.
Under the likelihood approach, we can use the likelihood-
based model-checking and model-selection procedures to
enhance the performance of the test [4].
After reviewing the simulation data, we were surprised
that the BH-FDR and LR-FDR methods produced so
high an FNDR when the difference was small, for ex-
ample, μ = 1. We need to improve the methods to ob-
tain robust results, even when the alternative and null
distributions overlap by so much. Another interesting
area of future research would be to study robust
models for various violations of model assumptions
using double hierarchical generalized linear models
[7,34]. Furthermore, the neuroimaging data are actu-
ally spatially correlated among the voxels. Owing to
the difficulty in specifying the full spatial dependency,
we assumed independence over voxels. Genovese, Roeder
and Wasserman [35] showed that exploiting the depend-
ency structure improved the power. Thus, a further exten-
sion of the LR-FDR method to a spatially correlated model
would be a promising prospect for future work.
Conclusions
We applied the LR-FDR method to PET data from AD
and QD patients and compared the performance to that
of conventional BH-FDR method. We found that theLR-FDR method enabled us to find more voxels with a
congruent distribution. Based on our findings from the
AD and QD PET subjects and our simulation study,
proving the increased efficiency, bilateral hippocampal
hypometabolism might serve as a marker for QD. It
would be interesting to extend this approach to perform
individual analyses of PET or MRI images to find a
meaningful region of brain. A prospective study of a co-
hort of subjects with QD (or MCI), in which individuals
might show a conversion to AD, is warranted, and the
LR-FDR method would prove advantageous in such
studies.
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